1. Home
  2. MEG vs MGTX Comparison

MEG vs MGTX Comparison

Compare MEG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$22.14

Market Cap

930.8M

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.14

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
MGTX
Founded
2012
2015
Country
United States
United States
Employees
3500
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.8M
909.1M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MEG
MGTX
Price
$22.14
$9.14
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$35.25
$24.57
AVG Volume (30 Days)
266.4K
715.9K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
93.69
33.02
EPS
N/A
N/A
Revenue
$830,538,000.00
$81,391,000.00
Revenue This Year
$5.41
$141.38
Revenue Next Year
$7.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.26
144.57
52 Week Low
$20.10
$6.21
52 Week High
$32.00
$11.85

Technical Indicators

Market Signals
Indicator
MEG
MGTX
Relative Strength Index (RSI) 52.09 43.91
Support Level $20.80 $8.82
Resistance Level $23.48 $9.65
Average True Range (ATR) 0.79 0.50
MACD 0.13 -0.10
Stochastic Oscillator 88.92 5.54

Price Performance

Historical Comparison
MEG
MGTX

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: